 |
PDBsum entry 4tpt
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4tpt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Discovery of a type III inhibitor of lim kinase 2 that binds in a dfg-Out conformation.
|
 |
|
Authors
|
 |
N.C.Goodwin,
G.Cianchetta,
H.A.Burgoon,
J.Healy,
R.Mabon,
E.D.Strobel,
J.Allen,
S.Wang,
B.D.Hamman,
D.B.Rawlins.
|
 |
|
Ref.
|
 |
Acs Med Chem Lett, 2015,
6,
53-57.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
The first allosteric, type III inhibitor of LIM-kinase 2 (LIMK2) is reported. A
series of molecules that feature both an N-phenylsulfonamide and tertiary amide
were not only very potent at LIMK2 but also were extremely selective against a
panel of other kinases. Enzymatic kinetic studies showed these molecules to be
noncompetitive with ATP, suggesting allosteric inhibition. X-ray crystallography
confirmed that these sulfonamides are a rare example of a type III kinase
inhibitor that binds away from the highly conserved hinge region and instead
resides in the hydrophobic pocket formed in the DFG-out conformation of the
kinase, thus accounting for the high level of selectivity observed.
|
 |
|
|
|
|
 |